Mar. 13 at 3:36 PM
$SLNO
Scorpion Capital
@ScorpionFund
·
3m
$SLNO Soleno Therapeutics. A second death now shown on FAERS database, Case ID 26462947 with the following info: female. 10 years old, 117 kg, event data Dec 12, 2025, FDA received date Mar 4, 2026. Submitted to FDA by a "healthcare professional." Given the event date, we are curious if Soleno was aware of this as of the last earnings call, when the CFO abruptly announced his resignation which seemed to be effective almost immediately
FAERS currently shows 300 total cases, of which 64 are serious with 2 deaths, on a small base of 859 active patients on drug as of Dec 31. Many of the serious cases indicate hospitalization + symptoms which are often associated with risk of fatal outcome. We are thus curious if any other of these 64 serious cases resulted in fatalities, and whether Soleno management is aware of additional undisclosed fatalities of patients who were on VYKAT XR.
Disclosure - We remain short Soleno Therapeutics
